Dr. Baumgart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-5863
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Brown UniversityResidency, Internal Medicine, 2007 - 2010
Albany Medical CollegeClass of 2007
Certifications & Licensure
NY State Medical License 2014 - 2025
RI State Medical License 2007 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 Start of enrollment: 2020 May 15
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09
Roles: Contact
- Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial Start of enrollment: 2024 Nov 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 37 citationsRandomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.Sarah B. Goldberg, Mary W. Redman, Rogerio Lilenbaum, Katerina Politi, Thomas E. Stinchcombe
Journal of Clinical Oncology. 2020-10-06 - 11 citationsA phase Ib/II study of pepinemab in combination with avelumab in advanced non–small cell lung cancerMichael Shafique, Terrence L. Fisher, Elizabeth E. Evans, John E. Leonard, Desa Rae Pastore
Clinical Cancer Research. 2021-07-01 - 4 citationsSafety and pharmacokinetics of docetaxel in combination with pegvorhyaluronidase alfa in patients with non-small cell lung cancer.Thomas C. Heineman, Megan Baumgart, Charvi Nanavati, Nash Gabrail, Scott A. Van Wart
Clinical and Translational Science. 2021-09-01
Press Mentions
Far from Home for the Holidays, Oral Cancer Survivor Finds Family in Team at Wilmot Cancer InstituteDecember 21st, 2021- Wilmot Cancer Institute in Trials for Drug to Treat Lung Cancer PatientsJune 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
